Onconetix, Inc. Share Price & Technical Analysis
ONCO · $0.95 (-5.94%)
Healthcare / Biotechnology
$0.95
-5.94%
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other p…
Price chart
Seasonality
Jun has 1 positive and 4 negative years (last 5 years shown)
-25% return in Jun, 0% avg return in past 3 year Jun month.
-280% return in 2026, -164% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -11% | -53% | -55% | -54% | -82% | -25% | – | – | – | – | – | – | -280% |
| 25 | -6% | -53% | -72% | -4% | 7% | -29% | -26% | -15% | 7% | 11% | -15% | -44% | -238% |
| 24 | -5% | -4% | -8% | -24% | 75% | -13% | -1% | -14% | -4% | -44% | -76% | -9% | -127% |
| 23 | 11% | -2% | -11% | 2% | -25% | 41% | 1% | -29% | -38% | -29% | -34% | -15% | -127% |
| 22 | – | -1% | 6% | -93% | 23% | -51% | 56% | -3% | -44% | -31% | -1% | -13% | -152% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Oversold
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.15M
P/E ratio
0
52W high
$361.3
52W low
$0.91
Volume
3,15,708
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹35,920
Abbott Laboratories Cede…
₹33,540
Eli Lilly And Company Ce…
₹30,700
Unitedhealth Group Inc C…
₹18,590
₹7,059
Frequently asked questions
- What is Onconetix, Inc. share price today?
- Onconetix, Inc. (ONCO) last traded around $0.95 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ONCO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ONCO. Download the app for real-time alerts.
- How can I analyze Onconetix, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.